Report: in Q1 2020, 62 VC funds raised a total of $21B in the US despite the pandemic crisis and invested $34.2B in 27% fewer deals than a year earlier
The spreading coronavirus pandemic has slammed tech startups, forcing dozens to shed thousands of jobs.
Context & Ripple Effects
Q1 2020 was the first full test of venture capital's pandemic footing: the global Q1 projection of $63.8B, down 17% from the prior quarter had already signaled a pullback, yet the 62 US funds tracked here still raised $21B and deployed $34.2B. The tell is the deal count — down 27% YoY — meaning the same or more money flowing through fewer checks.
That concentration pattern held all year: US VC hit a record $130B for 2020 even as deal volume fell for a second straight year, and when the Q2 slowdown picked up by mid-May as government stimulus rolled out, capital kept consolidating. The pandemic layoffs described here were the demand-side symptom of that same squeeze.
First-order effects
- Tech startups outside the favored few face immediate cuts — dozens shedding thousands of jobs — while the funds holding fresh $21B concentrate deployment into fewer, larger rounds rather than spreading it across new bets.
Second-order effects
- The Q2 data confirms the squeeze deepened before recovering: $34.3B across 2,197 deals, down 23% YoY, until stimulus rollout revived activity from mid-May — making government policy, not fund appetite, the swing factor for startup survival.
Third-order effects
- If the pattern holds, downturns structurally reprice early-stage risk: the same dynamic resurfaced in 2023, when PitchBook found angel and seed deals down roughly 50% YoY while total dollars fell about half as fast — a persistent barbell where late-stage incumbents absorb capital and the seed pipeline thins.
The trend: Venture capital is consolidating dollars into fewer, larger deals with each downturn, thinning the early-stage pipeline even in years of record total funding.